medigraphic.com
ISSN 1561-3070 (Electronic)

2019, Number 4

<< Back Next >>

Rev Cub Oftal 2019; 32 (4)

Concordance between clinical and anatomopathological diagnosis of palpebral malignancies

Rojas RI, Mendoza PMR, Vigoa AL, Miqueli RM, Rodríguez MS, Martínez RR

Language: Spanish
References: 17
Page: 1-12
PDF size: 339.69 Kb.


ABSTRACT

Objective: To assess the concordance between the initial and histopathological clinical diagnosis of malignant palpebral tumors.
Methods: An observational, descriptive and retrospective study of patients with different eyelid tumors was performed. The patients were treated in the Ocular Plastic Surgery Service of Ramón Pando Ferrer Cuban Institute of Ophthalmology, in the period from January to December of 2016, during which the clinical and pathological characteristics were described, together with the concordance between both diagnoses.
Results: The age group of 60-79 years predominated (46.1%), as it was with the female sex (51.7%) and the white skin color (92.6%). The lesions occurred mainly in the lower eyelid (77.0%) and telangiectasia constituted the most consistent sign of malignancy (56.8%), with a predominance of basal cell carcinoma, followed by spinocellular carcinoma (81.4% and 15, 2%, respectively). The concordance between the clinical and histopathological diagnosis was 69.2% for basal cell carcinoma; 9.7% for the spinocellular carcinoma; and 30% for the sebaceous carcinoma (Kappa index of 0.388, 0.262 and 0.357, respectively).
Conclusions: There is the greatest concordance between the clinical and histopathological diagnosis in basal cell carcinoma, but not in the rest of the tumors studied.


REFERENCES

  1. Kumar V, Abbas AK, Aster JC. Patología Básica. Robbin's Basic Pathology. Philadelphia: Elsevier; 2018.

  2. Huang YY, Liang WY, Tsai CC, Kao SC, Yu WK, Kau HC, et al. Comparison of the Clinical Characteristics and Outcome of Benign and Malignant Eyelid Tumors: An Analysis of 4521 Eyelid Tumors in a Tertiary Medical Center. Biomed Res Int. 2015;2015:453091-5.

  3. ljin A, Zieliński T, Antoszewski B, Sporny S. Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid. Postepy Dermatol Alergol. 2016;33(1):42-6.

  4. Rojas Rondón I, Agramonte IC, Río Torres M. Afecciones palpebrales. La Habana: Editorial Ciencias Médicas; 2018.

  5. Marzuka AG, Book SE. Basal Cell Carcinoma: Pathogenesis, Epidemiology, Clinical Features, Diagnosis, Histopathology, and Management. Yale J Biol Med. 2015;88(2):167-79.

  6. Wang CJ, Zhang HN, Wu H, Shi X, Xie JJ, He JJ, et al. Clinicopathologic features and prognostic factors of malignant eyelid tumors. Int J Ophthalmol. 2013;6(4):442-7.

  7. Spraul CW, Ahr WM, Lang GK. Clinical and histologic features of 141 primary basal cell carcinomas of the periocular region and their rate of recurrence after surgical excsion. Klin Monbl Augenheilkd. 2000;217(4):207-14.

  8. Ramírez García LK, Ortiz Ramos DL, Gómez Cabrera CG, Vigoa Aranguren L, Rojas Rondón I, Abreu Perdom FA. Caracterización clinicopatológica de los tumores malignos palpebrales. Rev Cubana Oftalmol. 2014;27(1):79-90.

  9. Leung C, Johnson D, Pang R, Kratky V. Identifying predictive morphologic features of malignancy in eyelid lesions: The LUI triage key. Can Fam Physician. 2015;61(1):e43-9.

  10. Khtibari Z, El Belhadji M, Benhmidoune L, Berrada S, Rqibate S, Amraoui A. Squamous cell carcinoma of the eyelids. Review of 7 years of experience of the adult ophthalmology service of the Casablanca university medical center. J Fr Ophtalmol. 2015;38(2):134-40.

  11. Imko-Walczuk B, Krys A, Lizakowski S, Debska-Slizien A, Rutkowski B, Biernat W, et al. Sebaceous carcinoma in patients receiving long-term immunosuppresive treatment: case report and literature review. Transplant Proc. 2014;46(8):2903-7.

  12. NCCN. Basal Cell Skin Cancer. Version 1.2016. NCCN Clinical Practice Guideline in Oncology. 2016 [access: 22/12/2017]. Available from: https://jnccn.org/view/journals/jnccn/14/3/articlep324. xml?print&print&print

  13. LeBoit PE, Burg G, Weedon D, Sarasin A. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Skin. Lyon: IARC Press; 2006.

  14. Domingo RE, Manganip LE, Castro RM. Tumors of the eye and ocular adnexa at the Philippine Eye Research Institute: a 10-year review. Clin Ophthalmol. 2015;9:1239-47.

  15. Kale SM, Patil SB, Khare N, Math M, Jain A, Jaiswal S. Clinicopathological analysis of eyelid malignancies - A review of 85 cases. Indian J Plast Surg. 2012;45(1):22-8.

  16. Mak ST, Chak-Ming Wong A, Yu-Fong Io I, Kwok-Kay Tse R. Malignant eyelid tumors in Hong Kong 1997-2009. Jap J Ophthalmol. 2011;55:681-5.

  17. Ho M, Liu DT, Chong KK, Ng HK, Lam DS. Eyelid tumours and pseudotumours in Hong Kong: a ten-year experience. Hong Kong Med J. 2013;19(2):150-5.




2020     |     www.medigraphic.com